Skip to content

Monolaurin

A monoglyceride of lauric acid, popular in antiviral and antimicrobial protocols.

  • CategoryImmune & Detox
  • FormGlycerol monolaurate
  • EvidenceNo supporting human trial

Where to get Monolaurin

iHerb
Glycerol monolaurate

Cam’s partner link opens iHerb on this product. No code needed; the link credits Cam.

Shop on iHerb

The short version

  • What it doesMonolaurin is glycerol monolaurate: one twelve-carbon lauric acid chain esterified to one hydroxyl of a glycerol. That is a surfactant.
  • Who it is forAntiviral protocols, in full knowledge of the evidence level.
  • What to watchGI upset and a 'die-off' or Herxheimer-like reaction reported when starting, which usually means starting too high.

How Monolaurin works

Glycerol monolaurate, a monoglyceride from lauric acid, disrupts the lipid envelope of enveloped viruses and the membranes of some bacteria. The selectivity comes from the envelope requirement — non-enveloped viruses are unaffected, which is a real limitation rather than a detail.

Monolaurin: serving, timing and spacing

Suggested serving
As directed, typically 600–3,000 mg daily.
How often
Daily
When
Away from food

General referenceA general reference intake for education, not a prescription. The label on the product you buy is the final word.

Good to know: Generally well tolerated. The gap between in-vitro promise and human evidence here is wide and has stayed wide for a long time — treat claims accordingly.

Research on Monolaurin3 evidence notes: clinical, correlative, theoretical

Each note sits under the kind of evidence it stands on. A thin or missing trial means nobody has run it yet, not that it doesn’t work. How the evidence tiers work

Human clinical evidence

  • No good human trials for the marketed antiviral or antibacterial uses.

Correlative data

  • Derived from lauric acid, which is abundant in coconut oil and human breast milk. The antimicrobial interest came from the observation that breast milk lipids inhibit enveloped viruses — again an observation about a food, not about a supplement.

Theoretical / extrapolated benefits

  • Demonstrated in-vitro activity against lipid-enveloped viruses and some bacteria, by disrupting the lipid envelope. Whether ingested monolaurin reaches meaningful systemic concentrations is not established — and it is a food additive precisely because it's digestible.

Sources read for this page

  • Schlievert PM, Peterson ML. Glycerol monolaurate antibacterial activity in broth and biofilm cultures. PLoS One 2012 · PMID 22808139
  • Li Q, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009 · PMID 19262509
  • Jiang Z, et al. Antimicrobial Emulsifier-Glycerol Monolaurate Induces Metabolic Syndrome, Gut Microbiota Dysbiosis, and Systemic Low-Grade Inflammation in Low-Fat Diet Fed Mice. Molecular Nutrition & Food Research 2018 · PMID 29131494

Monolaurin, the deep readThe mechanism, cell to human, which form, how you would know

What Monolaurin actually does

Monolaurin is glycerol monolaurate: one twelve-carbon lauric acid chain esterified to one hydroxyl of a glycerol. That is a surfactant. It has a greasy tail and a hydrophilic head, it partitions into lipid bilayers, and above a threshold concentration it destabilizes them. Everything the product is sold for follows from that single physical property, and so does everything wrong with the claim.

Two consequences of a physical mechanism. First, it is not selective: a molecule that disorders the envelope of a virus disorders any lipid membrane it reaches at sufficient concentration, which is why dose and location matter more than target identity. Second, resistance is hard to evolve against it — and that is exactly what was found. Glycerol monolaurate was at least 200-fold more bactericidal than lauric acid against Staphylococcus aureus and Streptococcus pyogenes in broth, and no resistance emerged after a year of passaging bacteria at half the minimum bactericidal concentration Schlievert 2012. A membrane is not a target you can mutate away from.

There is also a signaling effect, and it is the strongest in-vivo result the compound has. Applied vaginally in rhesus macaques, glycerol monolaurate inhibited production of the chemokine MIP-3alpha and protected the animals from simian immunodeficiency virus after repeated mucosal challenge Li 2009. That is not simple lysis — it is suppression of the epithelial signal that recruits the target cells the virus needs.

And here is the fact that decides whether any of it applies to a capsule. Monoacylglycerols are the normal end product of dietary fat digestion. Pancreatic lipase cleaves triglycerides into free fatty acids and 2-monoacylglycerol; enterocytes then re-esterify them back into triglyceride for packaging into chylomicrons. Glycerol monolaurate is a permitted food emulsifier precisely because the body treats it as food. A swallowed dose enters a system built to dismantle and reassemble exactly this class of molecule, which is why an oral route has no obvious path to a systemic antimicrobial concentration.

Cell, rodent, human — and where it stops

In broth. At least 200-fold greater bactericidal activity than lauric acid, with biofilm formation prevented and no resistance after a year of selection Schlievert 2012. Concentrations in that system are set by the experimenter in a fixed volume with no liver, no lipase and no blood.

In monkeys, applied to a surface. Intravaginal glycerol monolaurate, repeated high-dose SIV challenge, protection Li 2009. The route is topical. The drug is in contact with the tissue it is protecting.

In mice, swallowed — and this is the only oral animal data there is. Glycerol monolaurate given as a dietary emulsifier to mice on a low-fat diet induced metabolic syndrome, gut microbiota dysbiosis and systemic low-grade inflammation Jiang 2018.

In humans, for the marketed uses: nothing. No randomized trial of oral monolaurin for herpes simplex, for Epstein-Barr, for candida, for staphylococcal carriage or for anything else it is bought for.

So the obstacle here is not dose or population. It is route. Every positive result is in a dish or on a mucosal surface; the only oral result in an animal is a harm signal Jiang 2018. A capsule is neither of those things, and the step from “kills organisms in contact with it” to “kills organisms inside you after you swallow it” has never been attempted, let alone made.

And the number that would settle it does not exist. No study has ever reported a plasma glycerol monolaurate concentration in a human after an oral dose. Without that, the broth concentrations Schlievert 2012 cannot be compared to anything, in either direction. That gap has stayed open for decades, which is itself information about how hard anyone has tried.

Monolaurin — which form, and does it matter

“Monolaurin” on a label is usually a mixture. Commercial glycerol monolaurate is manufactured by esterification and typically contains 1-monolaurin, 2-monolaurin, dilaurin and trilaurin in some ratio. The studied species is the monoester Schlievert 2012 Li 2009, and the di- and tri- forms are ordinary fats. A product that does not state monoester content has not told you how much of the active it contains.

Lauric acid, coconut oil and monolaurin are three different purchases. Lauric acid is the fatty acid; the studies found the monoester at least 200-fold more active than the acid Schlievert 2012, so a coconut oil product is not a natural version of this. It is the weaker molecule.

Pellets against powder, and why it is not cosmetic. The commonest consumer format is a slow-dissolving pellet. Taken with a fatty meal, any monoacylglycerol is delivered into the exact enzymatic environment designed to process it. If there is a rational formulation question for this compound it is whether anything can be done to avoid lipase and bile, and nobody has published an attempt.

What would have to be true, and how you would know it was not

1. The prediction that cuts against the product, stated so it can be broken. At 600–3,000 mg/day, predict no change in anything systemic: hs-CRP flat, white cell count and differential flat, and no change in the antibody titre of any chronic viral infection. There is no evidence any of it reaches blood intact, and no human pharmacokinetic study exists to suggest otherwise.

2. The reframe for the reaction people report on starting. If glycerol monolaurate acts as a surfactant in the gut lumen, the predicted early effects are changes in stool form and in post-meal fullness within a few days — the same effects any emulsifier produces. That is a more parsimonious explanation for feeling rough in week one than a microbial kill, and it is distinguishable: an emulsifier effect tracks with meals and settles as the gut adapts, while nothing about it depends on which organism you believe you have.

3. A harm prediction with a marker, a direction and a window. The only oral animal study reports dysbiosis and systemic low-grade inflammation on chronic dietary exposure Jiang 2018. If that transfers, the human signature is hs-CRP drifting upward over months, not downward. Draw hs-CRP at baseline, 3 months and 6 months. This is the opposite of what is being bought, it follows from the best available oral evidence, and nobody has looked.

What will fool you here: the in-vitro record. It is real, it is strong, and it is doing all of the persuading. A 200-fold potency advantage in broth Schlievert 2012 is a fact about broth.

What nobody has tested yet

There is no human pharmacokinetics of any kind, and one study would end the argument. A single oral dose, plasma glycerol monolaurate by liquid chromatography-tandem mass spectrometry over eight hours, in ten people. If the answer is “below the limit of quantification”, every systemic claim for this product collapses at once; if it is not, the field has its first real number. It has never been published.

Nobody has tried to protect it from lipase. An enteric or lipase-resistant formulation against a plain one, measuring the same plasma concentration, is the obvious next experiment and there is no sign anyone has attempted it.

The contradiction between the two in-vivo results has never been addressed. Topical application protected macaques from a retrovirus Li 2009; dietary administration harmed mice Jiang 2018. Those are different species, doses and routes, and no study has put them in one design to find out which variable is responsible.

And there is no trial in the condition it is mostly bought for. Recurrent herpes simplex. Outbreak frequency over six months against placebo is a straightforward trial with a countable endpoint, and it does not exist.

Monolaurin — its own safety story, not its category's

Food-additive status is not a safety argument for this dose. Glycerol monolaurate is permitted as an emulsifier at the levels used in food. A supplement serving of 600 to 3,000 mg is a deliberate bolus of the isolated compound, and the two situations share a molecule and nothing else. Anybody citing GRAS status to justify a gram is quoting the wrong exposure.

The specific risk on this page is invisible to the person taking it. Chronic dietary glycerol monolaurate produced gut microbiota dysbiosis, metabolic syndrome and systemic low-grade inflammation in mice Jiang 2018. There is no human counterpart of that study, in either direction, and nothing a user would notice would tell them it was happening.

“No known drug interactions” means nobody has looked. There is no interaction study for this compound with anything. That is an absence of investigation, not a clean record, and the two get written the same way on labels.

No upper limit exists and nothing bounds one. Without a human pharmacokinetic study there is no exposure to compare a dose against; the practical ceiling is gastrointestinal tolerance, which is how most people find their dose and is not a safety assessment.

Who should not take it: anyone with a diagnosed infection using this instead of treatment — the human evidence for the marketed uses is zero, and a treatable infection left to a supplement is the actual harm here. And, on the emulsifier argument above, anyone with inflammatory bowel disease should treat a daily surfactant as a question for their gastroenterologist rather than a supplement decision.

Monolaurin safety basics3 points of its own

Its own safety story

  • GI upset and a 'die-off' or Herxheimer-like reaction reported when starting, which usually means starting too high.
  • No established significant drug interactions.
  • Long-term safety has not been characterized — the trials run weeks to months, not years. That is a real limit on what anyone can tell you about daily use for a decade. The human evidence base is thin relative to how it is marketed.

Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor. Pharmacists are underused and free.

Bloodwork to run4 tests in one order, code CAMERON

The effect itself has no blood test. That is a fact about the effect, and it changes how you should judge it.

  • What to watchNothing has been shown to move, and that is the finding. There are no good human trials for the antiviral or antibacterial uses this is bought for, so there is no validated endpoint to copy. If you run it anyway, the only defensible read is the frequency of whatever recurrent thing you are aiming at, counted monthly for three months before you start and three months after.
  • How long before it means anythingSix months split evenly around the start date, because a rate needs a denominator on both sides of it. Anything shorter is a story about one winter.
  • What will fool youThe in-vitro record, which is real and is doing all of the persuading. Monolaurin disrupts lipid envelopes in a dish; whether swallowing it reaches a concentration that matters in a person has never been established, and it is a permitted food additive precisely because it gets digested. That gap has stayed open for decades, which is itself information. It is not a substitute for treatment of a diagnosed infection.

The labs mapped to Monolaurin

4 tests in one order
Marek Diagnostics · no doctor’s visit
Code CAMERON
Order these 4 tests

Code CAMERON applies automatically at checkout. Draw before you start, not after: a result with nothing to compare it to answers nothing.

The Frequent Illness & Immune Resilience panel, explained

Monolaurin FAQ5 common questions

What is Monolaurin?
A monoglyceride of lauric acid, popular in antiviral and antimicrobial protocols.
What is the suggested dose of Monolaurin?
As directed, typically 600–3,000 mg daily. This is a general reference for education only. Statements have not been evaluated by the FDA and this is not medical advice.
Who is Monolaurin for?
Antiviral protocols, in full knowledge of the evidence level.
Which labs show whether Monolaurin is doing anything?
Complete Blood Count (CBC) with Differential, Vitamin D (25-Hydroxy), Zinc, Plasma, Comprehensive Metabolic Panel (CMP). Draw a baseline before you start, then recheck.
Where can I buy Monolaurin?
Coach Cam sources Monolaurin from vetted, top-rated brands on iHerb. Use the buy link on this page.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

The full stack plan is inside Skool

This page covers what Monolaurin is, what the research says and how people take it. Skool puts it in order alongside everything else you run, peptides included.

Free on this page

What Monolaurin is and how it works · The serving, its basis, and its safety lines · The research and the bloodwork that shows it

  • What Monolaurin is and how it works
  • The serving, its basis, and its safety lines
  • The research and the bloodwork that shows it

Members get

  • Monolaurin in your full stack: what it runs with, and what it cancels out
  • Its place in 1 Protocol Blueprint (Immune Resilience), week by week
  • The retest plan: Complete Blood Count (CBC) with Differential baseline, the recheck, what a change means
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational reference only. Not medical advice. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy on iHerbJoin Skool